Previous studies have shown that KMT5B overexpression reduces the proliferation of glioblastoma cells [24], and enhanced activity of KMT5B can suppress VEFGR2 expression in endothelial cells [25]. The gene discussed is KMT5B; the disease is glioblastoma.